MaxKober

Associate

Munich + 49.89.20.60.42.200

Connect:

Share

Max Kober advises clients in matters involving intellectual property law, with a focus on litigation.

Max has significant experience in patent and trade secret litigation as well as in trademark, design, and unfair competition law. Many of his cases are complex cross-border litigations involving numerous parties on different levels of the supply chains and require coordination across various jurisdictions. Max's practice also includes preliminary injunctions and enforcement of intellectual property rights during trade fairs and through custom seizures.

The clients he represents are active in a broad range of industries, including telecommunications, software, automotive, med tech, life sciences, and consumer products.

In recent years, Max litigated trade secret cases with a value of several hundred million euros. He further led a number of patent litigations against major telecommunication carriers and software companies.

Experience

  • CJ CheilJedang defends German patent infringement action by Japanese competitorJones Day represented CJ CheilJedang Corporation, a major Korean-based multinational company, in an international patent dispute with a Japanese competitor before the courts in Germany, including the Federal Supreme Court of Germany.
  • Plastic Omnium acquires ams OSRAM Automotive Lighting Systems from ams OSRAM GroupJones Day advised Plastic Omnium in the acquisition of the Automotive Lighting Systems (AMLS) business of ams OSRAM Group in a highly complex international carve-out transaction.
  • SAP wins summary judgment on Teradata trade secret and antitrust claimsJones Day successfully defended SAP, one of the world's leading producers of software for the management of business processes, against trade secret and antitrust claims in a lawsuit filed in the Northern District of California.
  • GeneoDx invests in PathoFinderJones Day represented Shanghai GeneoDx Biotech Company Limited, a subsidiary of Sinopharm Group, a leading pharmaceutical company in China, in connection with its investment in PathoFinder Holding B.V. (PFH), which is engaging in molecular diagnostics for the detection of pathogens causing an infectious disease in the Netherlands, by way of purchasing a majority stake in PFH.
  • Deutsche Beteiligungs AG sold investment in InfianaJones Day advised DBAG Fund VI, a fund advised by Deutsche Beteiligungs AG (DBAG), on the auction sale of the portfolio company Infiana Group GmbH and indirectly all of its subsidiaries to funds advised by Pamplona Capital Management.
  • Essilor acquires Brille24Jones Day advised Essilor International in the acquisition of 100% of Brille24 GmbH, one of the leading online retailers of optical products in Germany.
  • CORSAIR acquires Elgato GamingJones Day advised Corsair Gaming, Inc., a portfolio company of EagleTree Capital, in connection with the acquisition of the gaming division of Elgato Systems GmbH, which develops, designs and manufactures video game streaming software and hardware products.
  • SAP files DJ action in patent infringement dispute with Wellogix over computer softwareOn behalf of SAP America ("SAP"), Jones Day filed a patent infringement declaratory judgment action involving computer software, which is currently stayed in full pending the conclusion of reexamination proceedings filed by SAP in the USPTO involving the six patents-in-suit.
    • View All

    May 2022 Commentary

    Closing the "Injunction Gap": Overhaul of German Patent Act Speeds Up Litigation

    May 2022 Commentary

    Still Alive: The German "Automatic Injunction" in Patent Infringement Cases Under the New Patent Act

    April 2020 Commentary

    IP Protection of Artificial Intelligence in Europe: Tailor-Made Solutions Required

    Additional Publications

    Publications Prior to Jones Day

    April 2015

    Article on the Kochgefaess (cooking vessel) decision by the German Federal Court on January 13, 2015, which was published in Mitteilungen der deutschen Patentanwälte.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.